A diversified portfolio of 40-70 small-to mid-cap Australian companies.
Uses a rigorous bottom-up stock selection process that focuses on finding attractively valued companies with strong competitive positioning and sound company management.
A strong emphasis on building a diversified and balanced portfolio that aims to deliver more consistent returns through different market cycles.
Seeks to capture Australian large-caps of tomorrow, today.
An actively managed portfolio of 40-70 small to mid-cap Australian shares.
Offers investors a unique approach to portfolio construction which aims to deliver consistent returns through different market cycles.
James talks about what drives his passion for investing in Australian small and mid-caps, his investment philosophy, and where he is finding opportunities for the Fund.
James Abela, portfolio manager of the Fidelity Future Leaders Fund, talks about how he uncovers the future leaders of tomorrow through the Fund's tried and tested approach.
See for yourself how the fund has performed since inception. The chart below represents the value now of $10,000 invested in the Fidelity Future Leaders Fund in July 2013 compared with $10,000 invested in the S&P/ S&P/ASX Mid Small Index.
Chart as at: 30 June 2025
Total net returns represent past performance only. Past performance is not a reliable indicator of future performance. Returns of the Fund can be volatile and in some periods may be negative. The return of capital is not guaranteed. Benchmark: S&P/ASX Mid Small Index.
Net returns as at 30 June 2025
| Timeframe | 1 yr % |
3 yr % pa |
5 yr % pa |
7 yr % pa |
10 yr % pa |
Since inception (22/07/13) % pa |
|---|---|---|---|---|---|---|
| Fund | 17.69 | 16.35 | 8.84 | 8.11 | 11.24 | 11.35 |
| Benchmark | 14.48 | 11.89 | 10.11 | 7.19 | 9.77 | 9.50 |
| Active return | 3.21 | 4.46 | -1.27 | 0.92 | 1.47 | 1.85 |
Total net returns represent past performance only. Past performance is not a reliable indicator of future performance. Returns of the Fund can be volatile and in some periods may be negative. The return of capital is not guaranteed. Benchmark: S&P/ASX Mid Small Index.
Net as at 30 June 2025
| 1 yr % |
3 yr % pa |
5 yr % pa |
7 yr % pa |
10 yr % pa |
Since inception (22/07/13) % pa |
|
|---|---|---|---|---|---|---|
| Total return | 17.69 | 16.35 | 8.84 | 8.11 | 11.24 | 11.35 |
| Growth | 16.42 | 14.48 | 7.20 | 6.32 | 9.44 | 9.64 |
| Income | 1.27 | 1.87 | 1.65 | 1.79 | 1.80 | 1.71 |
Growth return is the unit price movement on exit to exit basis. Income is expressed as Total Return less growth component.
Total net returns represent past performance only. Past performance is not a reliable indicator of future performance. Returns of the Fund can be volatile and in some periods may be negative. The return of capital is not guaranteed. Benchmark: S&P/ASX Mid Small Index.
| Distribution | Distribution (CPU) | Reinvestment price |
|---|---|---|
| 30-Jun-25 | 432.8659 | $25.6904 |
CPU = cents per unit. The above cash CPU excludes imputation credits and foreign income tax offsets which are non-cash components and are reported in the end of year tax statement. If the Distribution CPU column is 0.0000 it means that nothing was distributed.
As at 31 May 2025
As at 31 May 2025
| % total net assets | |
|---|---|
| ALS LTD | 4.8% |
| TECHNOLOGY ONE LIMITED | 4.5% |
| SGH LTD | 4.2% |
| NETWEALTH GROUP LIMITED | 3.9% |
| FISHER & PAYKEL HEALTHCARE CORP | 3.8% |
| HUB24 LTD | 3.7% |
| BREVILLE GROUP LTD | 3.6% |
| CHARTER HALL GROUP | 3.6% |
| JB HI-FI LTD | 3.3% |
| LIFE360 INC | 3.2% |
As at 31 May 2025
| Fund % | Benchmark % | Relative % | |
|---|---|---|---|
| ALS LTD | 4.8 | 1.3 | 3.5 |
| NETWEALTH GROUP LIMITED | 3.9 | 0.7 | 3.2 |
| BREVILLE GROUP LTD | 3.6 | 0.5 | 3.1 |
| FISHER & PAYKEL HEALTHCARE CORP | 3.8 | 1.1 | 2.8 |
| HUB24 LTD | 3.7 | 1.2 | 2.5 |
As at 31 May 2025
| Fund % | Benchmark % | Relative % | |
|---|---|---|---|
| VICINITY CENTRES | 0.0 | 1.6 | -1.6 |
| WASHINGTON H SOUL PATTINSON & CO LTD | 0.0 | 1.6 | -1.6 |
| DEXUS | 0.0 | 1.3 | -1.3 |
| QUBE HOLDINGS LTD | 0.0 | 1.3 | -1.3 |
| RAMSAY HEALTH CARE LTD | 0.0 | 1.2 | -1.2 |
| Organisation | Rating / Recommendation |
|---|---|
| Lonsec |
Recommended4
The Lonsec report is only available to financial advisers, please contact us for a copy
|
| Morningstar | Silver5 |
| Zenith | Highly Recommended6 |
This Fund is subject to the risk of stock market fluctuations. Investors accessing the Fund through a master trust or wrap account will also bear any fees charged by the operator of such master trust or wrap account. Any apparent discrepancies in the numbers are due to rounding.
1 Management fees and costs are current as at the date shown above but may be subject to change in the future. Management fees and costs include management fees, estimated indirect costs, the net effect of GST and exclude abnormal expenses, transaction costs and any performance fee payable.
2Total returns (net) have been calculated using exit prices and take into account the applicable buy/sell spread and are net of Fidelity’s management costs, transactional and operational costs and assumes reinvestment of distributions. No allowance has been made for tax. Returns of more than one year are annualised. The return of capital is not guaranteed.
